Lilly said Japan is the second major market in which the drug has received approval, after the United States where it is sold ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

Pulses of light and sound seem to have beneficial effects. But some argue it is too soon to market experimental devices.

Among the adverse effects reported in the trial, infusion-related reactions were observed in 26.4% of patients in the ...

It also caused brain swelling in nearly a quarter of patients and brain bleeding in nearly a third ... Alzheimer's is the most common cause of dementia and accounts for about 60%-70% of the ...

A diagnosis in the early stages may allow you to start treatments that can slow disease progression.

Dozens of drugs to slow cognitive decline in dementia over the past decade have failed to show ... showing minor benefit while also raising the risk of brain bleeds, calling into question the general ...

Dementia is the biggest health challenge facing the UK ... These include swelling and /or bleeding on the brain called amyloid related imaging abnormalities (ARIA). “Switching on the immune system ...

Two new drug treatments prove effective in forestalling the start of early onset Alzheimer's; Roskamp will eventually offer infusion treatments ...

Infrequently, larger areas of bleeding in the brain can occur ... as well as people with mild dementia stage of early symptomatic Alzheimer's disease, with confirmed amyloid pathology.